---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-060235"
form_type: "8-K"
ticker: "COLL"
cik: "0001267565"
company_name: "COLLEGIUM PHARMACEUTICAL, INC"
filed_at: "2024-05-13T23:59:59+00:00"
generated_at: "2026-06-02T01:58:24.467926+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Collegium executes $35M accelerated share repurchase with Jefferies; initial 888,889 shares delivered

## Summary
- ASR agreement under $150M buyback program authorized in Jan 2024; $35M paid to Jefferies.
- Initial delivery of 888,889 shares based on $31.50 closing price on May 10, 2024 (~80% of expected total).
- Final number determined by VWAP during ASR term; settlement expected Q3 2024.
- As of March 31, 2024, outstanding shares ~32.7M, implying initial delivery covers ~2.7% of shares.

## SEC filing metadata
- accession: 0001104659-24-060235
- form_type: 8-K
- ticker: COLL
- cik: 0001267565
- company_name: COLLEGIUM PHARMACEUTICAL, INC
- filed_at: 2024-05-13T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1267565/000110465924060235/0001104659-24-060235-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1267565/000110465924060235/tm2414016d3_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-060235
- JSON: https://secwatch.observer/filing/0001104659-24-060235.json
- Plain text: https://secwatch.observer/filing/0001104659-24-060235.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.